Safety and immunogenicity of inactivated SARS-CoV-2 vaccine in high-risk occupational population: a randomized, parallel, controlled clinical trial - Infectious Diseases of Poverty - Infectious Diseas
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (COVID-19) have a substantial burden on health-care systems around the world. This is a randomized parallel controlled trial for asses…
Read More
Other Stories in Health
- New advisory offers evidence-based strategies to prevent postoperative delirium in older adults
- Wheat flour or Ragi flour: Which one is healthier?
- Keynote Selena Gomez spotlights prioritizing mental health during Academy Women's Luncheon
- UVM scientists discover new mechanism for blood flow regulation in the brain
- More cancer patients die here than in US, South Korea, Japan: Paper
- 'Yellowstone' Season 5 Episode 13 Recap: What Happened?
- Route to Christmas: Day 9 2024
- Depression genes amplify women's heart disease risk
- Measles & Rubella Weekly Monitoring Report – Week 20: May 12 to May 18, 2024
.png)
